Net Worth Advisory Group Makes New $765,000 Investment in HCA Healthcare, Inc. $HCA

Net Worth Advisory Group purchased a new position in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,639 shares of the company’s stock, valued at approximately $765,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Holos Integrated Wealth LLC bought a new position in shares of HCA Healthcare during the fourth quarter worth about $29,000. Palisade Asset Management LLC bought a new position in HCA Healthcare in the 3rd quarter worth about $26,000. Aventura Private Wealth LLC bought a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $34,000. Harbor Capital Advisors Inc. grew its holdings in HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after buying an additional 34 shares in the last quarter. Finally, JPL Wealth Management LLC acquired a new position in HCA Healthcare during the 3rd quarter worth $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA stock opened at $472.47 on Friday. The firm has a market cap of $105.63 billion, a PE ratio of 16.65, a P/E/G ratio of 1.45 and a beta of 1.34. HCA Healthcare, Inc. has a 12 month low of $314.43 and a 12 month high of $556.52. The firm has a 50 day simple moving average of $510.69 and a 200 day simple moving average of $475.97.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. The company had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company’s quarterly revenue was up 6.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio (DPR) is 10.99%.

Analysts Set New Price Targets

A number of brokerages recently weighed in on HCA. Robert W. Baird lifted their price objective on shares of HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. UBS Group boosted their price target on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a research report on Monday, February 23rd. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a report on Wednesday, March 4th. KeyCorp set a $503.00 target price on HCA Healthcare in a research report on Wednesday, January 28th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $537.73.

Insider Activity

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares in the company, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,214 shares of company stock valued at $7,797,595 over the last ninety days. Corporate insiders own 1.50% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.